Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents
NCT04792385
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
145
Enrollment
INDUSTRY
Sponsor class
Conditions
Safety
Interventions
DRUG:
E4/DRSP 15/3 mg combined tablet
Sponsor
Estetra